Patents Examined by Gina Justice
-
Patent number: 9655368Abstract: The invention provides for a low pH disinfectant composition that includes a relatively low amount of alcohol. Also provided is an article of manufacture that includes a textile and the composition, as well as methods of using the composition and article of manufacture (e.g., for reducing the number of microbes located upon a substrate, for killing or inhibiting a broad spectrum of microorganisms, for killing or inhibiting spore forming bacteria, and/or for disinfecting a substrate). The composition can optionally include a stable residual antimicrobial compound, thereby providing a combination of high-level disinfection and long-lasting residual effect.Type: GrantFiled: September 9, 2016Date of Patent: May 23, 2017Assignee: Medivators Inc.Inventors: Huyen Phuong Bui, Adam W. Hauser, Thomas M. Gentle, John J. Matta, Jonathan K. Olson
-
Patent number: 9648884Abstract: A sodium bicarbonate product comprises particles containing sodium bicarbonate and an organic material that is a solid at ambient temperature. The particles have a structure comprised of individual crystallites of sodium bicarbonate attached together in the particle. More than 95% by volume of the particles have a size less than 200 ?m. Particles of the product are hollow and are formed of an outer shell of the crystallites. The product may be used, for example, as a leavening agent in the production of cooked foods. The product may be produced by spray drying a solution or slurry dissolved organic material and dissolved sodium bicarbonate. The sodium bicarbonate may be present as a suspension.Type: GrantFiled: February 20, 2013Date of Patent: May 16, 2017Assignee: Eminate LimitedInventors: Sarah Gaunt, Stephen John Minter, Edna Elaine Best, Warren L. Nehmer
-
Patent number: 9649277Abstract: The present invention relates to a material in the form of solid particles with a diameter varying from 1 ?m to 1 cm which are composed of a continuous shell EExt comprising at least one silicon oxide, said shell EExt imprisoning at least one fatty phase, said material being characterized in that said fatty phase is solid at the storage temperature of said material and predominantly comprises a crystallizable oil having a melting point (TM) of less than 100° C. and in that said fatty phase includes at least one lipophilic substance of interest SL and at least one inclusion comprising a continuous shell EInt comprising at least one silicon oxide, said shell EInt imprisoning an aqueous phase comprising at least one hydrophilic substance of interest SH. The invention also relates to a process for the preparation of said material, to its use for the thermostimulated delivery of active substances, and also to the compositions including it.Type: GrantFiled: June 20, 2013Date of Patent: May 16, 2017Assignee: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Veronique Schmitt, Maxime Nollet, Martin Depardieu, Renal Backov
-
Patent number: 9642790Abstract: The present invention concerns an aqueous dispersion of multiphase polymer particles in which the polymer particles comprise at least two separate phases, the internal phase being formed by polymerization in the presence of a crosslinking agent, said dispersion further comprising a surfactant chosen from amino acid derivatives. The invention also concerns a film-forming composition comprising said aqueous dispersion of polymer particles. The invention also relates to a film obtained after application of said film-forming composition. This film dries very quickly, is water resistant, and has good adhesion, elasticity and breaking strength properties. The invention also concerns the use of said film for protecting surfaces of the skin or mucous membranes, wounds, injuries and/or skin disorders.Type: GrantFiled: June 7, 2013Date of Patent: May 9, 2017Assignees: Vivatech, Centre National de la Recherche Scientifique—CNRS, Ecole Superieure de Physique et Chimie Industrielles de la Ville de ParisInventors: Ludwik Leibler, Francois Tournilhac, Aggeliki Triftaridou, Eva-Maria Leuschner, Stephane Auguste, Jean-Marc Pernot
-
Patent number: 9616253Abstract: A water-absorbing polymer obtained from (A) a phosphate-containing (meth)acrylic monomer and/or a salt thereof, (B) a monomer having one (meth)acrylic group within the molecule and/or a salt thereof other than component (A), and (C) an organopolysiloxane having a (meth)acrylic group at both ends and related compositions.Type: GrantFiled: August 4, 2014Date of Patent: April 11, 2017Assignee: ELC Management LLCInventors: Fatemeh Mohammadi, Lisa Qu, Emi Akabane
-
Patent number: 9616110Abstract: Fabrication method for stratified and layered tissue to repair osteochondral defects. In a method of the present disclosure, the method comprises the step of applying a first direction magnetic field to a first quantity of a first collagen solution to align collagen within the first collagen solution in a first direction relative to the first direction magnetic field, forming a first layer of collagen. In a method of generating an aligned collagen layer of the present disclosure, the method comprises applying a first magnetic field at or greater than 0.1 Tesla to a layer of a first collagen solution defining a horizontal plane, within a temperature at or between 2° C. and 45° C., to generate an aligned collagen layer.Type: GrantFiled: February 28, 2014Date of Patent: April 11, 2017Assignee: Purdue Research FoundationInventors: Corey P. Neu, Tyler A. Novak, Garrett Shannon
-
Patent number: 9603801Abstract: The invention comprises a composition comprising a bioerodible porous silicon-based carrier material wherein the carrier material carries at least one large molecule therapeutic agent and at least one amorphous sugar, optionally further comprising a crystallization inhibitor. The composition may be used in vitro or in vivo to deliver the therapeutic agent, preferably in a controlled fashion over an intended period of time such as over multiple days, weeks or months. The composition may be used for treating or preventing conditions of a patient such as chronic diseases.Type: GrantFiled: March 14, 2014Date of Patent: March 28, 2017Assignee: pSivida US, Inc.Inventors: Christian Barnett, Paul Ashton, Leigh T. Canham
-
Patent number: 9592248Abstract: The invention provides methods and pharmaceutical compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and pharmaceutical compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a pharmaceutical composition comprising a prebiotic, optionally in combination with effective amount of a probiotic microbe or microbes.Type: GrantFiled: September 21, 2015Date of Patent: March 14, 2017Assignee: Ritter Pharmaceuticals, Inc.Inventors: Andrew J. Ritter, Dennis Savaiano, David Barnes, Todd Klaenhammer
-
Patent number: 9592199Abstract: This cellulose powder has: an average degree of polymerization of 100 to 350; a weight average particle size of over 30 ?m, but less than 250 ?m; an apparent specific volume of 2 to less than 15 cm3/g; and a particle size distribution sharpness of 1.5 to 2.9.Type: GrantFiled: May 30, 2013Date of Patent: March 14, 2017Assignee: ASAHI KASEI CHEMICALS CORPORATIONInventors: Kazuhiro Obae, Masayuki Kakizawa, Mitsuo Yamashita, Shinji Matsui
-
Patent number: 9579340Abstract: The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a prebiotic composition, optionally in combination with effective amount of a probiotic microbe or microbes.Type: GrantFiled: September 4, 2015Date of Patent: February 28, 2017Assignee: Ritter Pharmaceuticals, Inc.Inventors: Andrew J. Ritter, Dennis Savaiano, David Barnes, Todd Klaenhammer
-
Patent number: 9566222Abstract: The present invention relates to the activation of peptidyl arginine deiminase (PADs) 1 and/or 3 in the epidermis by at least one active agent used alone or in combination, namely caffeine, acefylline and/or theobromine in a cosmetic and/or pharmaceutical composition. The present invention also relates to the use of the aforementioned active agents in cosmetics and/or therapeutics, alone or in combination, in order to improve the barrier functions of the epidermis, to prevent and/or treat symptoms related to dry skin or to improve and/or promote hydration of the keratinous layer. Finally, the invention relates to increasing the activity of PAD1 and/or PAD3 in the epidermis.Type: GrantFiled: April 11, 2012Date of Patent: February 14, 2017Assignee: PIERRE FABRE DERMO-COSMETIQUEInventors: Hélène Duplan, Sylvie Daunes-Marion, Stéphane Poigny, Marie-Claire Mechin, Guy Serre, Michel Simon
-
Patent number: 9566300Abstract: The present invention provides a highly palatable colon cleansing formulation that utilizes a low chloride electrolyte-replenishing base solution. When formulated with polyethylene glycol and a selected sugar alcohol, the formulation offers the advantages of superior palatability without undesirable concomitant side effects or a decrease in cleansing efficacy.Type: GrantFiled: December 4, 2015Date of Patent: February 14, 2017Inventor: William A. Shaver
-
Patent number: 9566278Abstract: This disclosure concerns compounds which are useful as inhibitors of protein kinase C (PKC) and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC. This disclosure also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.Type: GrantFiled: September 9, 2015Date of Patent: February 14, 2017Assignee: RIGEL PHARMACEUTICALS, INC.Inventors: Rajinder Singh, Matthew Duncton, Jing Zhang, Salvador Alvarez, Kin Tso, Sacha Holland, Rose Yen, Rao Kolluri, Thilo Heckrodt, Yan Chen, Esteban Masuda, Hui Li, Donald G. Payan
-
Patent number: 9555037Abstract: A mammal undergoing an energy-based therapy is treated by administering at least one vasoconstrictive agent to the mammal prior to or during the procedure. The at least one vasoconstrictive agent is added in amounts sufficient to reduce or prevent vasodilation. This treatment method increases or promotes the size of the coagulation zone created after energy-based therapy.Type: GrantFiled: February 4, 2016Date of Patent: January 31, 2017Assignee: COVIDIEN AGInventor: Ronald J. Podhajsky
-
Patent number: 9526692Abstract: The present invention relates to compositions comprising a plant material and methods for using the same. The methods include extracting or removing a substance from a substrate, or remediating a substrate from a substance. The substance can comprise a hydrocarbon-containing substance, a protein, lipid, wax, fatty acid or fatty alcohol, grease, fat, oil or a combination thereof.Type: GrantFiled: March 14, 2014Date of Patent: December 27, 2016Assignee: GreenStract, LLCInventor: Peter Rehage
-
Patent number: 9526682Abstract: The present invention relates to a composition containing lipophilic phase (A), an emulsifying system (B), and an aqueous phase (C) that is preferably suitable for topical use, in particular cosmetic and/or dermatological use, in the form of a fine oil-in-water emulsion that is rich in oil and can be obtained by phase inversion, and to uses thereof in particular in the cosmetics or dermatological field.Type: GrantFiled: June 17, 2005Date of Patent: December 27, 2016Assignee: L'OREALInventors: Laurence Sebillotte-Arnaud, Odile Aubrun
-
Patent number: 9521851Abstract: A method of fabricating an antimicrobial metal complex surface, and the method includes providing an article, and the article has a first metal complex surface treated by anodization. The first metal complex surface is formed with a first pore. Secondly a silver suspension is provided. The silver suspension also has pore sealing agent. The article is soaked in the suspension to form a pore sealing layer having silver particles on the first metal complex surface such that the silver particles are distributed in the pore sealing layer. The antimicrobial metal complex surface fabricated by the method inhibits microorganism growth on the anodized metal surface.Type: GrantFiled: September 9, 2015Date of Patent: December 20, 2016Assignee: CATCHER TECHNOLOGY CO., LTD.Inventors: Chung-Cheng Lin, Feng-Ju Lai
-
Patent number: 9486560Abstract: Biodegradable polymer-coated surgical meshes formed into pouches are described for use with cardiac rhythm management devices (CRMs) and other implantable medical devices. Such meshes are formed into a receptacle, e.g., a pouch or other covering, capable of encasing, surrounding and/or holding the cardiac rhythm management device or other implantable medical device for the purpose of securing it in position, inhibiting or reducing bacterial growth, providing pain relief and/or inhibiting scarring or fibrosis on or around the CRM or other implantable medical device. Preferred embodiments include surgical mesh pouches coated with one or more biodegradable polymers that can act as a stiffening agent by coating the filaments or fibers of the mesh to temporarily immobilize the contact points of those filaments or fibers and/or by increasing the stiffness of the mesh by at least 1.1 times its original stiffness.Type: GrantFiled: September 23, 2013Date of Patent: November 8, 2016Assignee: TYRX, Inc.Inventors: Fatima Buevich, Frank Do, William McJames, Satish Pulapura, William Edelman, Arikha Moses, Mason Diamond, Shari Timothy
-
Patent number: 9480689Abstract: The present disclosure provides for compositions and methods of stimulating reproductive behavior and reproductive success and productivity in a suid, such as pigs. The composition may comprise at least one steroid hormone and a heterocyclic aromatic compound. The method comprises administering the pheromone composition to the suid for a period of time.Type: GrantFiled: November 17, 2015Date of Patent: November 1, 2016Assignee: Animal Biotech, LLCInventor: John J. McGlone
-
Patent number: 9474828Abstract: A composition kit for bone healing medical treatment, comprising partially deacetylated chitin (PDC) with a degree of deacetylation in the range of 40-75%. The composition is provided as a kit with a solids fraction and a liquid fraction, provided in separate vials and to be mixed just prior to use. The weight:weight ratio of the solids to liquid fraction is in the range from 1:1.2 to 1:6, and preferably from 1:1.5 to 1:4. The solids fraction comprises the PDC material and calcium phosphate and the liquid fraction comprises water and an acid.Type: GrantFiled: April 23, 2013Date of Patent: October 25, 2016Assignee: GENIS HF.Inventors: Johannes Gislason, Jon M. Einarsson, Chuen How Ng